These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1133 related articles for article (PubMed ID: 37489780)

  • 1. Tizanidine Induced Hypotension: Report of a Case and Review of the Literature.
    Mahajan R; Kalita J
    Curr Drug Saf; 2024; 19(2):313-316. PubMed ID: 37489780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypotension and bradycardia associated with concomitant tizanidine and lisinopril therapy.
    Publow SW; Branam DL
    Am J Health Syst Pharm; 2010 Oct; 67(19):1606-10. PubMed ID: 20852161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypotension following the initiation of tizanidine in a patient treated with an angiotensin converting enzyme inhibitor for chronic hypertension.
    Johnson TR; Tobias JD
    J Child Neurol; 2000 Dec; 15(12):818-9. PubMed ID: 11198499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypotension due to interaction between lisinopril and tizanidine.
    Kao CD; Chang JB; Chen JT; Wu ZA; Shan DE; Liao KK
    Ann Pharmacother; 2004 Nov; 38(11):1840-3. PubMed ID: 15383642
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Chen YJ; Li LJ; Tang WL; Song JY; Qiu R; Li Q; Xue H; Wright JM
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD008170. PubMed ID: 30480768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-line drugs inhibiting the renin angiotensin system versus other first-line antihypertensive drug classes for hypertension.
    Xue H; Lu Z; Tang WL; Pang LW; Wang GM; Wong GW; Wright JM
    Cochrane Database Syst Rev; 2015 Jan; 1():CD008170. PubMed ID: 25577154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of antihypertensive therapy with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in combination with calcium channel blockers for stroke prevention.
    Talbert RL
    J Am Pharm Assoc (2003); 2010; 50(5):e116-25. PubMed ID: 20833609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profound hypotension in a tetraplegic patient following angiotensin-converting enzyme inhibitor lisinopril. Case report.
    Schmitt JK; Koch KS; Midha M
    Paraplegia; 1994 Dec; 32(12):871-4. PubMed ID: 7708426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.
    Li EC; Heran BS; Wright JM
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD009096. PubMed ID: 25148386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Angiotensin converting enzyme inhibitor intoxication: Naloxone to the rescue? Naloxone for ACE inhibitor intoxication.
    Robert M; De Bels D; Chaumont M; Honoré PM; Gottignies P
    Am J Emerg Med; 2019 Jun; 37(6):1217.e1-1217.e2. PubMed ID: 30952604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aconite poisoning presenting as hypotension and bradycardia.
    Chan TY
    Hum Exp Toxicol; 2009 Dec; 28(12):795-7. PubMed ID: 19880659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of chronic angiotensin converting enzyme inhibition on sympathetic nerve traffic and baroreflex control of the circulation in essential hypertension.
    Grassi G; Turri C; Dell'Oro R; Stella ML; Bolla GB; Mancia G
    J Hypertens; 1998 Dec; 16(12 Pt 1):1789-96. PubMed ID: 9869013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
    Shaman AM; Smyth B; Arnott C; Palmer SC; Mihailidou AS; Jardine MJ; Gallagher MP; Perkovic V; Jun M
    Clin J Am Soc Nephrol; 2020 Aug; 15(8):1129-1138. PubMed ID: 32675281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resistant Hypertension On Treatment (ResHypOT): sequential nephron blockade compared to dual blockade of the renin-angiotensin-aldosterone system plus bisoprolol in the treatment of resistant arterial hypertension - study protocol for a randomized controlled trial.
    Cestário EDES; Fernandes LAB; Giollo-Júnior LT; Uyemura JRR; Matarucco CSS; Landim MIP; Cosenso-Martin LN; Tácito LHB; Moreno H; Vilela-Martin JF; Yugar-Toledo JC
    Trials; 2018 Feb; 19(1):101. PubMed ID: 29433578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.
    ; Yusuf S; Teo K; Anderson C; Pogue J; Dyal L; Copland I; Schumacher H; Dagenais G; Sleight P
    Lancet; 2008 Sep; 372(9644):1174-83. PubMed ID: 18757085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Severe hypotension during spinal anesthesia induced by angiotensin-converting enzyme inhibitors].
    Sierra P; Sabaté S; Castaño J; Galcerán JM
    Med Clin (Barc); 2008 Nov; 131(17):676-7; author reply 677-8. PubMed ID: 19087797
    [No Abstract]   [Full Text] [Related]  

  • 19. The hemodynamic effects of anesthetic induction in vascular surgical patients chronically treated with angiotensin II receptor antagonists.
    Brabant SM; Bertrand M; Eyraud D; Darmon PL; Coriat P
    Anesth Analg; 1999 Dec; 89(6):1388-92. PubMed ID: 10589613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urocortin 2 in patients with hypertension treated with angiotensin converting enzyme inhibitors or angiotensin receptor blockers.
    Walczewska J; Siga O; Dzieza-Grudnik A; Krolczyk J; Wizner B; Wolkow PP; Borys A; Kolton-Wroz M; Gryglewska B; Grodzicki T
    J Physiol Pharmacol; 2019 Apr; 70(2):. PubMed ID: 31443094
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.